Need a specific person's email?
Browse NiKang Therapeutics Inc.'s employee directory (about 36 employees) and reveal verified emails free.
NiKang Therapeutics Inc.'s most common email format is First.Last@nikangtx.com (ex. John.Doe@nikangtx.com), used for 92% of nikangtx.com addresses. NiKang Therapeutics Inc. uses 4 email patterns.
| Format | Example | Share of nikangtx.com |
|---|---|---|
| First.Last@nikangtx.comMost common | John.Doe@nikangtx.com | |
| First.Middle@nikangtx.com | John.Michael@nikangtx.com | |
| Last@nikangtx.com | Doe@nikangtx.com | |
| FirstMiddle.Last@nikangtx.com | JohnMichael.Doe@nikangtx.com |
Browse NiKang Therapeutics Inc.'s employee directory (about 36 employees) and reveal verified emails free.
Biotechnology ResearchDelaware, United States11-50 Employees
NiKang Therapeutics, Inc. is a privately held biotech company based in Wilmington, Delaware, focused on discovering and developing novel small molecule therapies for cancer. Its work centers on oncology drug discovery with an aim to create first-in-class or best-in-class targeted treatments and immuno-oncology agents to address cancer in patients. The company operates within the biotechnology research sector and positions itself as a developer of targeted therapies designed to improve cancer treatment options. NiKang’s activities are oriented toward advancing small molecule programs through discovery and development phases, collaborating with partners in the broader oncology field. A recent development includes presenting a discovery at a major cancer conference, highlighting progress in a CDK2/4 dual degrader designed for cancer therapy. The organization is headquartered in the greater Wilmington area and has a scale appropriate to a specialized biotech company pursuing early-stage-to-mid-stage research collaborations and programs.
Most common format
First.Last@nikangtx.com
Example: John.Doe@nikangtx.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.